InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 3 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding InMed Pharmaceuticals Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 20 | 19 | −1 |
| Shares | 944.9K | 560.2K | −384.7K (−40.7%) |
| Value | $2.99M | $979.9K | −$2.01M (−67.2%) |
New holders (2)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 11,344 | $20.0K | 0.00% |
| Gables Capital Management Inc. | 30 | $0 | 0.00% |
Sold out (3)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Penserra Capital Management LLC | 19,912 | $49.0K |
| Reilly Financial Advisors, LLC | 700 | $2.00K |
| Advisory Services Network, LLC | 151 | $0 |